NCT07199192View on ClinicalTrials.gov

Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
HypoxemiaSevere Acute Respiratory Syndrome
Interventions
DRUG

Corticosteroid

systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days or until discharge

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER